Logotype for Colabor Group Inc

Colabor Group (GCL) Q1 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Colabor Group Inc

Q1 2025 earnings summary

23 Nov, 2025

Executive summary

  • Q1 2025 revenue grew 0.4% year-over-year to $131.7 million, driven by distribution volume growth, new and existing clients, and the Beaudry & Cadrin asset acquisition, partially offset by a lower-margin contract renewal and restaurant sector slowdown.

  • Adjusted EBITDA fell to $2.3 million (1.7% margin) from $4.9 million (3.7% margin) year-over-year, mainly due to a major contract repricing at lower margin.

  • Net loss from continuing operations increased to $4.0 million ($0.04/share) from $1.8 million ($0.01–$0.02/share) year-over-year, mainly due to lower adjusted EBITDA and higher non-operating costs.

  • Cash flow from operating activities was $6.2 million, down from $11.7 million, impacted by higher working capital needs and lower EBITDA.

  • The company is focused on expanding in Western Québec, improving product and customer mix, and leveraging local supply chains to benefit from the buy-local trend.

Financial highlights

  • Q1 2025 sales increased 0.4% to $131.7 million; distribution revenues up 3%, wholesale down 3.8%.

  • Adjusted EBITDA: $2.3 million (1.7% margin), down from $4.9 million (3.7% margin) year-over-year.

  • Net loss: $4.0 million, compared to $1.8 million year-over-year.

  • Cash flow from operations: $6.2 million, down from $11.7 million year-over-year.

  • Net debt: $47.1 million, down from $47.8 million at year-end 2024.

Outlook and guidance

  • Gross margin is expected to improve sequentially through 2025 due to seasonality and a higher mix of independent restaurant clients, though not to prior-year levels due to the institutional contract repricing.

  • The company anticipates continued market share gains and customer growth, especially in Western Québec, and expects the impact from renewed institutional supply agreement at lower margins.

  • Full benefits of margin mitigation actions are expected to materialize over time, with ongoing focus on productivity, product mix, and prudent financial management.

  • Closing of the Alimplus/Mayrand Plus acquisition is expected in Q2 2025, expanding reach and customer base.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more